Mayo Clinic’s Heart Transplant programs is the largest integrated transplant center with three locations across the nation. Our heart transplant experts discuss our program and the benefits of collaboration when referring a patient to our teams.
Our heart transplant doctors and surgeons use proven innovations to successfully treat people with congestive heart failure and other serious heart diseases. Their experience in using advanced technology, specialized procedures and an integrated approach focused on the patient makes Mayo Clinic a leader in transplant outcomes.
Refer a patient
Learn more about early referrals for patient with advanced heart failure.
there are millions of people walking around every day doing okay with their their diagnosis of congestive heart failure, but it's those individuals who continue to experience symptoms refractory symptoms if you will, who should be considered candidates for cardiac transplantation. When a patient primarily is unable to walk a short amount of distance when they're hospitalized two times a year or more, you have low blood pressures or when they have a dangerous heart rhythm that frequently leads to defibrillator firings. Those are indications that you have more advanced heart failure. When those indications occur, on average, patients have less than two years of survival and it's the two year survival point that we utilize to say the benefits outweigh the risk for cardiac transplantation. We try whenever possible to work collaboratively with physicians in the community and to share care wherever possible. We're going to make every effort to get that patient in in a timely fashion. We will minimize any amount of work that that position may have to do to facilitate that patient getting in to see us. There are specific patients that other centers sent to. Os congenital heart disease would be one of them and multi organ transplantation will be another one. Multi organ transplants probably occurs around 15% of all heart transplants that occur in the United States with heart and kidney, together being the most common and we have a very collaborative practice work very closely with the liver and lung and kidney surgeons and have a very robust multi organ program. We are able to expand and offer transplant to patients with some conditions that were historically thought of as non compatible with transplant. Those are patients with amyloid induced cardiomyopathy. These both er and al amyloid. We say that there's never too soon for a patient to come here. Whether it's an innovative approach to treatment electrical problems of the heart, there's always something we can do. We can develop significant advances in transplantation and we can share that seamlessly with the other groups. The same can be true. It's a two way street. They share their experiences with us as well. For example, different type of medication approach to immuno suppression that we have developed. We have shared uh different techniques and approaches to managing patients while awaiting transplant. Mechanical support. You name it. We have a yes approach. If one of our colleagues is contacting us and telling us that they need a second set of eyes on a particular patient. Our approach is yes.
